definiens: shall mean, with re spect to worldwide sales or other dispositions of Diagnostic Product(s ), the total gross amount invoi ced by GlycArt, GlycArt ’s Affiliates or GlycArt ’s sublicensees to end users, distributors or agents i n a bona fide arms - length transaction with an unrel ated Third Party after deduction of ( a ) actual volume discount s, sales rebates, allowances, deduction of returns and ( b ) sales taxes ( e.g. value added taxes ) and other taxes dire ctly linked to the sales but not profits ( provided that such taxes are separately invoiced to such end users, distribu tors or agents ), less the following lump sum deduct ions from the foregoing net amount for : Sales Expenses in the amount of [ * * * ] Reagent Rental Expenses in the amount of [ * * * ] Third Party Royalty Expenses In the event one or more Diagnostic Product(s ) is / a re sold together with one or more other diagnostic or therapeutic product(s ) at a single price ( such comb ination is hereinafter referred to as ), such single price shall be allocated amo ng the Diagnostic Product(s ) and the other product ( s ) in the Diagnostic Combination Product based on the market price for such products when sold separately . If an y such Diagnostic Product is not being sold alone with a m arket price, ICT and GlycArt shall agree upon a fai r market price for that Diagnostic Product solely . This pric e agreed upon shall be used to calculate Diagnostic Net Sales